Hormone Receptor Positive Tumor Not Yet Recruiting Phase 2 Trials for Tamoxifen (DB00675)

IndicationStatusPhase
DBCOND0075370 (Hormone Receptor Positive Tumor)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03917082Limited Adjuvant Endocrine Therapy for Low Risk Breast CancerTreatment